155 related articles for article (PubMed ID: 11215377)
1. [New anticoagulants].
Kawasaki T; Hirayama F
Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):275-82. PubMed ID: 11215377
[TBL] [Abstract][Full Text] [Related]
2. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
[TBL] [Abstract][Full Text] [Related]
3. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
[TBL] [Abstract][Full Text] [Related]
4. Emerging anticoagulants: mechanism of action and future potential.
Klement P; Rak J
Vnitr Lek; 2006 Mar; 52 Suppl 1():119-22. PubMed ID: 16637459
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of coagulation factors: advances in antithrombotic therapy.
Bauer KA
Semin Thromb Hemost; 2002 Jun; 28 Suppl 2():15-24. PubMed ID: 12073176
[TBL] [Abstract][Full Text] [Related]
6. New anticoagulants.
Bauer KA
Curr Opin Hematol; 2008 Sep; 15(5):509-15. PubMed ID: 18695376
[TBL] [Abstract][Full Text] [Related]
7. New antithrombotic agents.
Hirsh J; Weitz JI
Lancet; 1999 Apr; 353(9162):1431-6. PubMed ID: 10227240
[TBL] [Abstract][Full Text] [Related]
8. New antithrombotics in the prevention of thromboembolic disease.
Yavin YY; Wolozinsky M; Cohen AT
Eur J Intern Med; 2005 Aug; 16(4):257-66. PubMed ID: 16084352
[TBL] [Abstract][Full Text] [Related]
9. Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?
Laux V; Perzborn E; Heitmeier S; von Degenfeld G; Dittrich-Wengenroth E; Buchmüller A; Gerdes C; Misselwitz F
Thromb Haemost; 2009 Nov; 102(5):892-9. PubMed ID: 19888525
[TBL] [Abstract][Full Text] [Related]
10. Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke.
Martí-Fàbregas J; Mateo J
Cerebrovasc Dis; 2009; 27 Suppl 1():111-9. PubMed ID: 19342840
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation beyond direct thrombin and factor Xa inhibitors: indications for targeting the intrinsic pathway?
van Montfoort ML; Meijers JC
Thromb Haemost; 2013 Aug; 110(2):223-32. PubMed ID: 23739841
[TBL] [Abstract][Full Text] [Related]
12. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
Savelieva I; Bajpai A; Camm AJ
Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
[TBL] [Abstract][Full Text] [Related]
13. Ximelagatran: a new oral anticoagulant.
Hrebickova L; Nawarskas JJ; Anderson JR
Heart Dis; 2003; 5(6):397-408. PubMed ID: 14633322
[TBL] [Abstract][Full Text] [Related]
14. Current anticoagulant therapy--unmet clinical needs.
Hirsh J
Thromb Res; 2003 Jul; 109 Suppl 1():S1-8. PubMed ID: 12818628
[TBL] [Abstract][Full Text] [Related]
15. Protein C.
Esmon CT
Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulant drugs: an update.
Kwaan HC; Samama MM
Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):511-22. PubMed ID: 15225111
[TBL] [Abstract][Full Text] [Related]
17. The use and limitations of unfractionated heparin.
Krishnaswamy A; Lincoff AM; Cannon CP
Crit Pathw Cardiol; 2010 Mar; 9(1):35-40. PubMed ID: 20215909
[TBL] [Abstract][Full Text] [Related]
18. New anticoagulants: from bench to bedside.
Haas S; Schellong S
Hamostaseologie; 2007 Feb; 27(1):41-7. PubMed ID: 17279275
[TBL] [Abstract][Full Text] [Related]
19. Direct Factor Xa and direct thrombin inhibitors: a clinical trial update.
Turpie AG
Curr Opin Drug Discov Devel; 2009 Jul; 12(4):497-508. PubMed ID: 19562646
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic drugs in vascular medicine: a historical perspective.
Schrör K
Semin Vasc Med; 2003 May; 3(2):97-105. PubMed ID: 15199472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
